In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price ...
In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...
Acelyrin (NASDAQ:SLRN) announced Thursday a decision to adopt a limited-duration stockholder rights plan, also known as a poison pill, after Tang Capital Partners rapidly accumulated 8.8% of the ...
Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...
HC Wainwright reissued their buy rating on shares of Alumis (NASDAQ:ALMS – Free Report) in a report published on Monday,Benzinga reports. They currently have a $19.00 price objective on the stock. A ...
They’ve been a model of social housing since the Middle Ages but almshouses are suffering from the unintended consequences of ...
At the traffic junction at ITO in central Delhi, a girl in a torn frock weaves through the idling cars, tapping on windows ...
Shares of Alumis Inc. (NASDAQ:ALMS – Get Free Report) have been given a consensus rating of “Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports.
The National Alms Agency (Baznas) of Indonesia has voiced its commitment to leveraging the Islamic philanthropic funds it ...
The death toll from Sunday’s tragic stampede at an alms-giving event in Bauchi State has risen to seven, police confirmed on ...
When we show our children how the Lenten pillars work together, we help them have a fruitful season where they have a chance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results